Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases
Beta-adrenoceptor Activation Reduces Host Viral Resistance by Preventing IFN-γ Production in Liver NK Cells
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Cognitive Decline and Alzheimer’s Linked to Low Systemic REST Levels and Deficient Stress Protection of the Aging Brain
Rhinovirus Infections via ATP Release May Trigger IL-33 Production by Bronchial Smooth Muscle Cells: Implications for AsthmaJanuary 31, 2017
New Evidence Linking Clusterin and Other Complement Proteins to Alzheimer’s Progression and PredictionSeptember 15, 2016
Brain Endothelial Cells Identified as the Source of Prostaglandin E2 – the Major Trigger of Fever ResponseNovember 5, 2014
An Association between Widespread Pain and Serum IL-8 Levels in Fibromyalgia PatientsNovember 9, 2015
Coping with Stress and Subtypes of Burnout Linked To Specific Detrimental Coping StrategiesApril 28, 2014
Interleukin-33 Reverses Cognitive Deficits in Alzheimer’s Mouse Model Showing Promise as a Therapeutic TargetApril 27, 2016
Secukinumab (Selective IL-17A Inhibitor) Shows Promise as a New Treatment for Ankylosing SpondylitisDecember 30, 2014
